SLC22A10 Antibodies

AND SLC22A10 ELISA kits, SLC22A10 Proteins

Many biological assays use antibodies to detect SLC22A10, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with SLC22A10 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop SLC22A10 antibodies...

We validate the specificity of these antibodies to SLC22A10 by testing them on tissues known to express SLC22A10 positively and negatively. Browse below to find the SLC22A10 antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: CLEC2A

SLC22A10 Infographic by Boster Bio

All SLC22A10 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-SLC22A10 Antibody Picoband®

Human

ELISA, Flow Cytometry, WB

$370
Cat # A15610-1
100 µg/vial

SLC22A10 Overview

Facts about Solute carrier family 22 member 10.

SLC22A10 3D structure. Source: alphafold

Solute carrier family 22 member 10 (SLC22A10)

Gene Information

Human
Gene Name:	SLC22A10
Uniprot:	Q63ZE4
Entrez:	387775

Family

Belongs to:

major facilitator (TC 2.A.1) superfamily

Alternative Names

member 10; solute carrier family 22, member 10

Molecular Weight

Mass (kDA):
60.257 kDA

Genomic Context


Human

Location:	11q12.3
Sequence:	11; NC_000011.10 (63268257..63311983)

Tissue Specificity

Detected in fetal and adult liver, and in adult kidney.

Subcellular Localizations

Membrane; Multi-pass membrane protein.

Diseases

Malignant Neoplasms
Malignant Neoplasm Of Breast

Pathways

Transport
Carnitine Transport
Response To Drug

PTMs

Glycoprotein

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/SLC22A10

References

PMID: 15221005 by Yamada S., et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.

PMID: 11327718 by Sun W., et al. Isolation of a family of organic anion transporters from human liver and kidney.